Business Leadership
CRB Names Experienced Business Leader as CFO
CRB
PR-M01-22-04Jan 05, 2022
M&A
AbbVie Issues Large Bond to Finance Allergan Merger
Nice Insight
PAO-M11-19-NI-006Nov 12, 2019
IPO
BridgeBio Pharma Announces Pricing of Its Initial Public Offering
BridgeBio Pharma
PR-M06-19-NI-060Jun 28, 2019
Series B Financing
Whole Biome Raises $35 Million in Series B Financing
Emilie Branch
Pharma's Almanac
PAO-M06-19-NI-002Jun 13, 2019
Financing
Thrive Earlier Detection Gets Funding from Third Rock to Develop Cancer Detection Tech
Pharma's Almanac
PAO-M06-19-NI-001Jun 13, 2019
Finance
SAGA Raises 40 Million SEK (€3.7 Million) to Advance Ultrasensitive Cancer Liquid Biopsies
SAGA Diagnostics
PR-M06-19-NI-009Jun 12, 2019
Investment
Boehringer Ingelheim Investing in Mexico
Nice Insight
PAO-M05-19-NI-033May 31, 2019
Financing
Schrödinger Announces Close of Latest Financing, Raising a Total of $110 Million
Schrödinger
PR-M05-19-NI-062May 22, 2019
Series A Financing
Syncona founds Quell Therapeutics with £35 million Series A Financing
Syncona Ltd
PR-M05-19-NI-063May 22, 2019
Announcement
Nestlé Enters into Exclusive Negotiations to Sell Nestlé Skin Health to a Consortium Led by EQT and ADIA
Nestle Health Science
PR-M05-19-NI-053May 17, 2019
Investment
Fengate Exceeds Fundraising Target and Closes Core Infrastructure Fund III with $1.1 Billion in Capital Commitments
Fengate
PR-M05-19-NI-046May 16, 2019
Financing
KNOW Bio Announces Closing of $30 Million in Equity Financing
KNOW Bio, LLC
PR-M05-19-NI-048May 16, 2019
Drug Pricing
Gene Therapy Costs Discussed by Insurance Company Heads
Emilie Branch
Pharma's Almanac
PAO-M05-19-NI-010May 10, 2019
Financing
KIYATEC Announces $3 Million Initial Closing of Series B2 Preferred Stock Financing and New Investor LabCorp
KIYATEC, Inc.
PR-M05-19-NI-031May 10, 2019
Earnings
Invitae Reports 47% Growth in Quarterly Revenue and Volume Year-Over-Year
Invitae
PR-M05-19-NI-026May 09, 2019
Earnings
Insulet Reports First Quarter 2019 Revenue of $159.6 Million, an Increase of 29% Year-Over-Year
Nice Insight
PR-M05-19-NI-021May 07, 2019
Series C Financing
Sirnaomics Closes $47 Million Series C Financing to Develop RNAi Therapeutics for Treatment of Cancer and Fibrotic Diseases
Sirnaomics, Inc.
PR-M04-19-NI-091Apr 30, 2019
Finance
Perrigo Increases Its Dividend By 11%
Perrigo
PR-M04-19-NI-090Apr 30, 2019
Finance
Pharma Company Tax Savings Went to Investors and Stock Buybacks
Nice Insight
PAO-M04-19-NI-017Apr 18, 2019
Finance
WuXi Biologics Continues to Deliver Record Results
WuXi Biologics
PR-M03-19-NI-052Mar 19, 2019